| Dr Mark Paul Rheaume, MD | |
|
960 Joe Frank Harris Pkwy Se, Cartersville, GA 30120-2129 | |
| (770) 607-7339 | |
| (678) 928-9759 |
| Full Name | Dr Mark Paul Rheaume |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 22 Years |
| Location | 960 Joe Frank Harris Pkwy Se, Cartersville, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811177884 | NPI | - | NPPES |
| GRP1205 | Other | GA | GROUP MEDICARE ID |
| 137013442 | Medicaid | GA | |
| 511I300172 | Other | MEDICARE ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 054657 (Georgia) | Secondary |
| 2085R0204X | Radiology - Vascular & Interventional Radiology | 054657 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Tanner Medical Center - Carrollton | Carrollton, GA | Hospital |
| Piedmont Henry Hospital | Stockbridge, GA | Hospital |
| Piedmont Mountainside Hospital Inc | Jasper, GA | Hospital |
| Tanner Medical Center Villa Rica | Villa rica, GA | Hospital |
| Cartersville Medical Center | Cartersville, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Truffles Vein Center Llc | 1355594797 | 10 |
| Summit Radiology Services Pc | 3577454024 | 47 |
News Archive
A new study disputes the effectiveness of mortality as a measure of the quality of care provided by hospitals to stroke patients. The paper - which was simultaneously presented today at the International Stroke Conference in San Diego and published in the journal Stroke - found that use of do-not-resuscitate orders differ widely between hospitals and that this variation can significantly skew a hospital's quality "ranking" based on mortality.
VeriChip Corporation and its development partner RECEPTORS LLC, a technology company whose AFFINITY by DESIGN chemistry platform can be applied to the development of selective binding products, announced today that VeriChip plans to fund its existing development partnership with RECEPTORS to launch Phase II development of an in vivo glucose-sensing RFID microchip.
Sylentis, a biopharmaceutical subsidiary of Grupo Zeltia and a pioneer in the research and development of new drugs based on gene silencing (interference RNA, RNAi), has completed Phase Ia of its first clinical trial with SYL040012 in the form of ophthalmic drops to treat elevated intraocular pressure and glaucoma.
New research published in Science Advances investigates the relationship between wildfire smoke and COVID-19 mortality using pollution and COVID-19 incidence and mortality data.
› Verified 6 days ago
| Entity Name | Toccoa Clinic Medical Associates, Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609896885 PECOS PAC ID: 5597652164 Enrollment ID: O20040301000262 |
News Archive
A new study disputes the effectiveness of mortality as a measure of the quality of care provided by hospitals to stroke patients. The paper - which was simultaneously presented today at the International Stroke Conference in San Diego and published in the journal Stroke - found that use of do-not-resuscitate orders differ widely between hospitals and that this variation can significantly skew a hospital's quality "ranking" based on mortality.
VeriChip Corporation and its development partner RECEPTORS LLC, a technology company whose AFFINITY by DESIGN chemistry platform can be applied to the development of selective binding products, announced today that VeriChip plans to fund its existing development partnership with RECEPTORS to launch Phase II development of an in vivo glucose-sensing RFID microchip.
Sylentis, a biopharmaceutical subsidiary of Grupo Zeltia and a pioneer in the research and development of new drugs based on gene silencing (interference RNA, RNAi), has completed Phase Ia of its first clinical trial with SYL040012 in the form of ophthalmic drops to treat elevated intraocular pressure and glaucoma.
New research published in Science Advances investigates the relationship between wildfire smoke and COVID-19 mortality using pollution and COVID-19 incidence and mortality data.
› Verified 6 days ago
| Entity Name | Summit Radiology Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174572374 PECOS PAC ID: 3577454024 Enrollment ID: O20040323001388 |
News Archive
A new study disputes the effectiveness of mortality as a measure of the quality of care provided by hospitals to stroke patients. The paper - which was simultaneously presented today at the International Stroke Conference in San Diego and published in the journal Stroke - found that use of do-not-resuscitate orders differ widely between hospitals and that this variation can significantly skew a hospital's quality "ranking" based on mortality.
VeriChip Corporation and its development partner RECEPTORS LLC, a technology company whose AFFINITY by DESIGN chemistry platform can be applied to the development of selective binding products, announced today that VeriChip plans to fund its existing development partnership with RECEPTORS to launch Phase II development of an in vivo glucose-sensing RFID microchip.
Sylentis, a biopharmaceutical subsidiary of Grupo Zeltia and a pioneer in the research and development of new drugs based on gene silencing (interference RNA, RNAi), has completed Phase Ia of its first clinical trial with SYL040012 in the form of ophthalmic drops to treat elevated intraocular pressure and glaucoma.
New research published in Science Advances investigates the relationship between wildfire smoke and COVID-19 mortality using pollution and COVID-19 incidence and mortality data.
› Verified 6 days ago
| Entity Name | Northeast Georgia Physicians Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891745212 PECOS PAC ID: 6901898386 Enrollment ID: O20040402001277 |
News Archive
A new study disputes the effectiveness of mortality as a measure of the quality of care provided by hospitals to stroke patients. The paper - which was simultaneously presented today at the International Stroke Conference in San Diego and published in the journal Stroke - found that use of do-not-resuscitate orders differ widely between hospitals and that this variation can significantly skew a hospital's quality "ranking" based on mortality.
VeriChip Corporation and its development partner RECEPTORS LLC, a technology company whose AFFINITY by DESIGN chemistry platform can be applied to the development of selective binding products, announced today that VeriChip plans to fund its existing development partnership with RECEPTORS to launch Phase II development of an in vivo glucose-sensing RFID microchip.
Sylentis, a biopharmaceutical subsidiary of Grupo Zeltia and a pioneer in the research and development of new drugs based on gene silencing (interference RNA, RNAi), has completed Phase Ia of its first clinical trial with SYL040012 in the form of ophthalmic drops to treat elevated intraocular pressure and glaucoma.
New research published in Science Advances investigates the relationship between wildfire smoke and COVID-19 mortality using pollution and COVID-19 incidence and mortality data.
› Verified 6 days ago
| Entity Name | Truffles Vein Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760733448 PECOS PAC ID: 1355594797 Enrollment ID: O20130114000391 |
News Archive
A new study disputes the effectiveness of mortality as a measure of the quality of care provided by hospitals to stroke patients. The paper - which was simultaneously presented today at the International Stroke Conference in San Diego and published in the journal Stroke - found that use of do-not-resuscitate orders differ widely between hospitals and that this variation can significantly skew a hospital's quality "ranking" based on mortality.
VeriChip Corporation and its development partner RECEPTORS LLC, a technology company whose AFFINITY by DESIGN chemistry platform can be applied to the development of selective binding products, announced today that VeriChip plans to fund its existing development partnership with RECEPTORS to launch Phase II development of an in vivo glucose-sensing RFID microchip.
Sylentis, a biopharmaceutical subsidiary of Grupo Zeltia and a pioneer in the research and development of new drugs based on gene silencing (interference RNA, RNAi), has completed Phase Ia of its first clinical trial with SYL040012 in the form of ophthalmic drops to treat elevated intraocular pressure and glaucoma.
New research published in Science Advances investigates the relationship between wildfire smoke and COVID-19 mortality using pollution and COVID-19 incidence and mortality data.
› Verified 6 days ago
| Entity Name | Tanner Imaging Center |
|---|---|
| Entity Type | Part B Supplier - Independent Diagnostic Testing Facility (idtf) |
| Entity Identifiers | NPI Number: 1154820876 PECOS PAC ID: 8325475056 Enrollment ID: O20200219000803 |
News Archive
A new study disputes the effectiveness of mortality as a measure of the quality of care provided by hospitals to stroke patients. The paper - which was simultaneously presented today at the International Stroke Conference in San Diego and published in the journal Stroke - found that use of do-not-resuscitate orders differ widely between hospitals and that this variation can significantly skew a hospital's quality "ranking" based on mortality.
VeriChip Corporation and its development partner RECEPTORS LLC, a technology company whose AFFINITY by DESIGN chemistry platform can be applied to the development of selective binding products, announced today that VeriChip plans to fund its existing development partnership with RECEPTORS to launch Phase II development of an in vivo glucose-sensing RFID microchip.
Sylentis, a biopharmaceutical subsidiary of Grupo Zeltia and a pioneer in the research and development of new drugs based on gene silencing (interference RNA, RNAi), has completed Phase Ia of its first clinical trial with SYL040012 in the form of ophthalmic drops to treat elevated intraocular pressure and glaucoma.
New research published in Science Advances investigates the relationship between wildfire smoke and COVID-19 mortality using pollution and COVID-19 incidence and mortality data.
› Verified 6 days ago
| Entity Name | Regenerative Spine And Pain Specialists |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578193355 PECOS PAC ID: 2163851528 Enrollment ID: O20200406001938 |
News Archive
A new study disputes the effectiveness of mortality as a measure of the quality of care provided by hospitals to stroke patients. The paper - which was simultaneously presented today at the International Stroke Conference in San Diego and published in the journal Stroke - found that use of do-not-resuscitate orders differ widely between hospitals and that this variation can significantly skew a hospital's quality "ranking" based on mortality.
VeriChip Corporation and its development partner RECEPTORS LLC, a technology company whose AFFINITY by DESIGN chemistry platform can be applied to the development of selective binding products, announced today that VeriChip plans to fund its existing development partnership with RECEPTORS to launch Phase II development of an in vivo glucose-sensing RFID microchip.
Sylentis, a biopharmaceutical subsidiary of Grupo Zeltia and a pioneer in the research and development of new drugs based on gene silencing (interference RNA, RNAi), has completed Phase Ia of its first clinical trial with SYL040012 in the form of ophthalmic drops to treat elevated intraocular pressure and glaucoma.
New research published in Science Advances investigates the relationship between wildfire smoke and COVID-19 mortality using pollution and COVID-19 incidence and mortality data.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark Paul Rheaume, MD Po Box 200096, Cartersville, GA 30120-9002 Ph: (678) 928-9759 | Dr Mark Paul Rheaume, MD 960 Joe Frank Harris Pkwy Se, Cartersville, GA 30120-2129 Ph: (770) 607-7339 |
News Archive
A new study disputes the effectiveness of mortality as a measure of the quality of care provided by hospitals to stroke patients. The paper - which was simultaneously presented today at the International Stroke Conference in San Diego and published in the journal Stroke - found that use of do-not-resuscitate orders differ widely between hospitals and that this variation can significantly skew a hospital's quality "ranking" based on mortality.
VeriChip Corporation and its development partner RECEPTORS LLC, a technology company whose AFFINITY by DESIGN chemistry platform can be applied to the development of selective binding products, announced today that VeriChip plans to fund its existing development partnership with RECEPTORS to launch Phase II development of an in vivo glucose-sensing RFID microchip.
Sylentis, a biopharmaceutical subsidiary of Grupo Zeltia and a pioneer in the research and development of new drugs based on gene silencing (interference RNA, RNAi), has completed Phase Ia of its first clinical trial with SYL040012 in the form of ophthalmic drops to treat elevated intraocular pressure and glaucoma.
New research published in Science Advances investigates the relationship between wildfire smoke and COVID-19 mortality using pollution and COVID-19 incidence and mortality data.
› Verified 6 days ago
Dr. Kevin Garrett Miller, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 960 Joe Frank Harris Pkwy Se, Cartersville, GA 30120 Phone: 678-928-9759 Fax: 678-928-9759 | |
Dr. Derek Brett Pollard, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 960 Joe Frank Harris Pkwy Se, Cartersville, GA 30120 Phone: 678-928-9759 Fax: 678-928-9759 | |
Adam Kyle Deal, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 960 Joe Frank Harris Pkwy Se, Cartersville, GA 30120 Phone: 770-386-1530 Fax: 770-607-1019 | |
Dr. Daniel Andrew Ortiz, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 960 Joe Frank Harris Pkwy Se, Cartersville, GA 30120 Phone: 678-905-7053 | |
Dr. Robert E Kim, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 960 Joe Frank Harris Pkwy Se, Cartersville, GA 30120 Phone: 678-928-9759 Fax: 678-928-9759 | |
Dr. James Darrell Darling, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 960 Joe Frank Harris Pkwy Se, Cartersville, GA 30120 Phone: 770-607-7339 Fax: 770-607-0789 | |
Dr. Qiao Zhou, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 10 Bowen Ct, Cartersville, GA 30120 Phone: 707-607-7339 Fax: 410-354-0186 |